At Averto Medical, our leadership team brings together decades of expertise in medical innovation, engineering, regulatory affairs, and finance. With a shared commitment to advancing colorectal surgery and improving patient outcomes, we are pioneering cutting-edge solutions that redefine postoperative care.
A visionary in medical device innovation, Dr. Kenton Fong leads Averto Medical with a passion for transforming patient care. As a Stanford-trained plastic and reconstructive surgeon, he has pioneered groundbreaking wound care and surgical technologies, holding 50+ patents and developing solutions used by hundreds of thousands of patients worldwide. Prior to founding Averto Medical, Dr. Fong co-founded Curaseal and Spiracur (acquired by 3M), spearheading life-changing advancements in medical technology.
With 25+ years of experience in medical device R&D, product development, and commercialization, Jeffrey Etter has led teams that have designed and launched dozens of medical devices currently used in hospitals worldwide. His expertise spans regulatory approval, manufacturing scale-up, and engineering leadership. Named on over 40 patents, his work has been instrumental in securing over $125 million in funding and driving the acquisition of six companies totaling over $1 billion.
A leader in regulatory strategy and clinical development, Dr. Grace Carlson brings 20+ years of experience in guiding medical devices through FDA and CE Mark approval. She has played a critical role in regulatory success at DFine, Peak Surgical, and Free Flow Medical, ensuring that cutting-edge technologies reach the patients who need them most. Her expertise in clinical trials, quality systems, and product strategy strengthens Averto Medical’s position at the forefront of surgical innovation.
Bringing 25+ years of finance leadership, Brian Talbert specializes in scaling early-stage medical technology companies from R&D through commercialization. With a strong engineering background and extensive experience in fundraising and financial strategy, he provides crucial insights that drive Averto Medical’s growth and innovation. His expertise spans life sciences, semiconductors, and consumer products, making him a key player in bringing disruptive medical solutions to market.
Our expert leadership team, backed by decades of innovation, regulatory excellence, and engineering expertise, is committed to revolutionizing surgical care. With the ColoSeal ICD System, we are changing the way colorectal surgery is performed, ensuring better patient outcomes and enhanced recovery solutions for surgeons worldwide.
